# Study on the Effect and Mechanism of Aescine Sodium in the Treatment of Allergic Rhinitis

> **NCT06709079** · NA · NOT_YET_RECRUITING · sponsor: **Cheng Lei** · enrollment: 60 (estimated)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Aescine Sodium Tablets (Ocai®, Green Leaf Pharmaceuticals)

## Key facts

- **NCT ID:** NCT06709079
- **Lead sponsor:** Cheng Lei
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12
- **Primary completion:** 2025-12
- **Final completion:** 2026-09
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06709079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06709079, "Study on the Effect and Mechanism of Aescine Sodium in the Treatment of Allergic Rhinitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06709079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*